MFDS announces change order, temporarily wrapping up the ‘olmesartan’ issue

The Ministry of Food and Drug Safety(MFDS) held the Central Pharmacists Deliberation Committee, and announced the change order of the olmesartan’s approval after reviewing its relevant safety information.

According to the change order, the MFDS added an article stating ‘It cannot be re-administered on patients who were confirmed in a biopsy’ in the precaution. The order can be interpreted as ...